Our locations
Brisbane - Translational Research Institute
Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia
Partnership Programs
AdvanCell operates a comprehensive partnership program for taking novel Targeted Alpha Therapies from the lab through to Phase I and beyond.
cGMP ISOTOPE
AdvanCell provides its cGMP isotope to partners removing reliance on external supply chains.
CMC
AdvanCell’s in-house manufacturing team and infrastructure ensures CMC development to meet FDA requirements.
CLINICAL TRIALS
AdvanCell has deep experience in running clinical trials for radioligand therapies.
AUSTRALIAN
Australia’s world-leading Nuclear Medicine expertise and infrastructure offers a smooth and competitive path for clinical development.
Looking to partner for Targeted Alpha Therapy Development?
Get in touch
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.